Can a special PET scan spot hidden prostate cancer after focal therapy?
Diagnosis
Not yet recruiting
This trial investigates whether Posluma, a PSMA-targeted PET scan, can accurately detect any remaining or returning prostate cancer about 12 months after focal therapy. Researchers will compare the scan results with MRI and biopsy data in 22 men with intermediate-risk, organ-conf…
Phase: PHASE2 • Sponsor: Aditya Bagrodia • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC